Clinical trial
Intermittent Therapy in HIV-1 Infected Patients With Successful Viral…
NCT00122551 · French National Agency for Research on AIDS and Viral Hepatitis, Other · Terminated
Key facts
| NCT number | NCT00122551 |
|---|---|
| Title | Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART) |
| Official title | A Prospective, Randomized, Multicenter Trial of Intermittent Therapy in HIV-Infected Patients With Successful Viral Suppression Under HAART (ANRS 106 Window Trial) |
| Lead sponsor | French National Agency for Research on AIDS and Viral Hepatitis, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Procedure |
| Interventions | Intermittent antiretroviral therapy |
| Enrollment | 400 |
| Start date | Dec 1, 2001 |
| Completion | Apr 1, 2005 |
| First posted | Jul 22, 2005 |
| Last update posted | Aug 1, 2005 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: